MENURogel Cancer Center at ASCO 2025
Media contact: Nicole Fawcett, 734-764-2220
The American Society of Clinical Oncology’s annual meeting will be May 30 to June 3, 2025, at McCormick Place Convention Center in Chicago. Rogel Cancer Center and University of Michigan researchers will be represented in presentations and poster sessions. Check the list below to support your colleagues. All times listed are Central Time.
Follow the meeting on X/Twitter at #ASCO25 and be sure to tag @UMRogelCancer in your posts.
Note: Search results are often incomplete. If your abstract is missing from this list, reach out to [email protected].
May 31
ABSTRACTS
Esophageal Cancer: Current Standards in an Ever-Changing Treatment Landscape
Bryan J. Schneider; Case-Based Panel
1:15-2:15 p.m. | Hall D1
Results from phase 1 study of mycophenolate mofetil with chemoradiation in newly diagnosed glioblastoma to target de-novo purine metabolism to overcome treatment resistance
Yoshie Umemura, Nathan Clarke, Wajd Al-Holou, Ameer Elaimy, Andrew Scott, Denise Leung, Michelle Kim, Sean Ferris, Jennifer Thomas, Jason Heth, Matthew Schipper, Krithika Suresh, Theodore Lawrence, Daniel Wahl
3:30-3:36 p.m. | S102
Poster session: 9 a.m.-noon, Hall A
Characterization of CLDN18 expression in a Western biliary tract cancer population.
Alexander Bray, Jiaqi Shi, Chandan Kumar, Nicole Peterson, Vaibhav Sahai
Abstract 4090, Poster Bd 380
Poster session: 1:30-4:30 p.m., Hall A
T-cell effector cytokine signature as predictor of survival and toxicity in metastatic NSCLC patients treated with immunotherapy
Varshini Odayar, Jadyn James, Michael Green, Nithya Ramnath
Abstract 8555, Poster Bd 35
Hospice utilization in Veterans with newly diagnosed metastatic prostate cancer.
Jennifer Lee, Kyle Kumbier, Jennifer Burns, Jordan Sparks, Archana Radhakrishnan, Phoebe Tsao, Amanda Malus, Lauren Gauntlett, Samuel Washington III, Timothy Hofer, Ted Skolarus, Lauren Wallner, Brent Hollenbeck, Vahakn Shahinian, Megan Caram
Abstract 11146, Poster Bd 485
Association of MammaPrint and clinical outcomes by race among 5000 individuals with HR+HER2- early stage breast cancer enrolled in FLEX.
Erin Cobain, Priyanka Sharma, Kent Hoskins, Michael Berry, Gregory Vidal, J. Jaime Alberty-Oller, Nicole Gordon, Harshini Ramaswamy, Nicole Stivers, Andrea Menicucci, William Audeh, Joyce O'Shaughnessy
Abstract 11147, Poster Bd 486
The Genetic Information and Family Testing (GIFT) trial.
Steven Katz, Paul Abrahamse, Rachel Hodan, Timothy Hofer, Kevin Ward, Ann Hamilton, Lawrence An, Allison Kurian
Abstract LBA10606, Poster Bd 331
Enhancing lung cancer surgical quality: Insights from a national quality improvement collaborative.
Kelley Chan, Eileen Reilly, Ryan Jacobs, Tashea Coates, Amanda Francescatti, Kimberly Rodriguez, Raheem Bell, Linda Martin, Matthew Facktor, Kirtee Raparia, John Hamm, Matthew Katz, Anthony Yang, Ronald Weigel, David Odell
Abstract 11140, Poster Bd 479
June 01
Poster Session: 9 a.m.-noon, Hall A
Novel analysis of 3-y results from the pivotal EPCORE NHL-1 study: Outcomes in patients (pts) with relapsed/refractory large B-cell lymphoma (R/R LBCL) and complete response (CR) at 2 y with epcoritamab (epcor) monotherapy.
Yasmin Karimi, Julie Vose, Michael Clausen, David Cunningham, Umar Farooq, Tatyana Feldman, Hervé Ghesquieres, Wojciech Jurczak, Kim Linton, Tycel Phillips, Won Kim, Pegah Jafarinasabian, Milan Geybels, David Soong, Barbara Månsson, Christian Eskelund, Mohammad Atiya, Martin Hutchings, Catherine Thieblemont, Chan Cheah
Abstract 7043, Poster Bd 226
Total metabolic tumor volume for predicting cytokine release syndrome and treatment response in patients receiving bispecific antibodies for B-cell lymphoma.
Xi Yang, Shelbie Cingoranelli, Tycel Phillips, Iman Ahmed, Victoria Nachar, Jonathan Weiss, Shannon Carty, Ryan Wilcox, Benjamin Viglianti, Yasmin Karimi
Abstract 7059, Poster Bd 242
Oncologists’ perspectives on challenges using chemotherapy, immune checkpoint inhibitors, and targeted kinase inhibitors for metastatic cancer.
Christine Veenstra, Nathaniel Wilson, Paul Abrahamse, Allison Kurian, Sarah Hawley, Ann Hamilton, Kevin Ward, Steven Katz
Abstract 1548, Poster Bd 314
Shorespan-007: Phase 3 study of bomedemstat versus hydroxyurea in essential thrombocythemia naive to cytoreductive therapy.
Kristen Pettit, Yuka Sugimoto, Eran Zimran, Yoshimitsu Shimomura, Hiroki Yamaguchi, Hans Hasselbach, Jean-Jacques Kiladjian, Steffen Koschmieder, Harinder Gill, Natalia Curto-Garcia, Alejandro Berkovits, Ahmet Muzaffer Demir, Tsai-Yun Chen, Stefan Scheding, Claudia Carmona, Alessandro Vannucchi, Keita Kirito, Shiyu Zhang, Uzor Ogbu, David Ross
Abstract TPS6587, Poster Bd 199b
June 02
ABSTRACTS
Multidisciplinary Treatment of Anaplastic Thyroid Cancer
Francis P. Worden, moderator
8-9 a.m. | S102
Unintended Consequences of Multicancer Early Detection: The Population Health and Value Perspective
A. Mark Fendrick
10-10:15 a.m. | S102
Subgroup analysis of the phase 2 part of the RINGSIDE phase 2/3 trial of varegacestat for treatment of desmoid tumors.
Rashmi Chugh
12:36-12:42 p.m. | S504
Redefining Treatment Paradigms in the Era of Biomarker Driven Risk-Adaptive Cancer Therapy
Paul Swiecicki
3-3:12 p.m. | S102
Poster Session 9 a.m.-noon, Hall A
Antibody drug conjugates treatment response score (ADC TRS) for sequencing trastuzuamb deruxtecan (T-DXd) and sacituzumab govitecan (SG) in advanced breast cancer (aBC).
Andi Cani, Scott Tomlins, Bryan Johnson, Stephanie Bush, Michael Nitchie, Katarina Robinson, Jasie Inman, Ryan White, Komal Plouffe, Daniel Rhodes, Erin Cobain
Abstract 1053, Poster Bd 32
Practice patterns related to ovarian function suppression in the SWOG S2010 clinical trial of young women with breast cancer.
Norah Henry, Joseph Unger, Amy Darke, Anne Schott, Pankaj Kumar, Marcela Mazo- Canola, Claire Sathe, Paula Cabrera-Galeana, Alice Kengla, Michael Fisch, Dawn Hershman
Abstract 522, Poster Bd 115
Transcriptional profiling to identify a program of enzalutamide extreme non-response in lethal prostate cancer.
Anbarasu Kumaraswamy, Ya-Mei Hu, Joel Yates, Chao Zhang, Shangyuan Ye, Charles Ryan, David Quigley, Rahul Aggarwal, Robert Reiter, Tomasz Beer, Matthew Rettig, Martin Gleave, Primo Lara Jr., Josh Stuart, George Thomas, Felix Feng, Eric Small, Zheng Xia, Joshi Alumkal
Abstract 5084, Poster Bd 283
A randomized, open-label, phase 2b study of the BET bromodomain inhibitor (BETi) ZEN-3694 plus enzalutamide vs. enzalutamide in patients with metastatic castration resistant prostate cancer (mCRPC).
Rahul Aggarwal, Michael Schweizer, Christopher Chay, Omkar Marathe, Emilio Araujo-Mino, David Morris, David Nanus, Mohit Narang, Alexander Spira, Ian Schnadig, Sarah Attwell, Emily Johnson, Philip Wegge, Vandy Xu, Helena Zhu, Alissa McGuire, Margo Snyder, Michael Sweeney, Sanjay Lakhotia, Joshi Alumkal
Abstract TPS5123, Poster Bd 315b
Poster Session 1:30-4:30 p.m., Hall A
Oncologists' attitudes and beliefs toward crying with patients and its correlation with burnout.
Hannah Catzen, Janice Firn, Laura Taylor, Harry Rubin-Falcone, Christine Veenstra, Shitanshu Uppal
Abstract 9013, Poster Bd 2
Social genomic mechanisms of health disparities among adolescent/young adult survivors of Hodgkin and non-Hodgkin lymphoma: ECOG-ACRIN EAQ211.
Brad Zebrack, Fenghai Duan, Steven Cole, Ilana Gareen, Pinki Prasad, Jorean Sicks, Christabel Cheung, Andrew Evens, Shira Dinner, Adam DuVall, Susan Parsons, John Salsman, Brad Kahl, Melissa Simon, Lynne Wagner
Abstract TPS12137, Poster Bd 156b
Phase 1 dose-escalation trial of talazoparib in combination with belinostat in select advanced solid tumors.
Monika Burness, Ulka Vaishampayan, Kelley Kidwell, Heidi Egloff, Vaibhav Sahai, Erin Cobain, Mark Zalupski, Anne Schott
Abstract 3043, Poster Bd 358
June 03
ABSTRACTS
Breast Cancer - Local/Regional/Adjuvant
Jacqueline Sara Jeruss
Highlights of the Day Session | 8-8:15 a.m. | Hall D1
Publication Only
Pilot study of intestinal microbiome alteration with resistant potato starch (RPS) in patients (pts) treated with dual immune checkpoint inhibitors (ICI).
Nathaniel Wilson, Amy Chang, Nicole Cady, Muneesh Tewari, Tom Schmidt, Thomas Braun, Christopher Lao, Leslie Fecher
Response adapted oncologic surgery following neoadjuvant immunotherapy and chemotherapy for resectable locally advanced oral cavity and oropharyngeal squamous cell carcinoma.
Moneb Bughrara, Francis Worden, Zachary Buxo, Colleen Hochfelder, Steven Chinn, Michelle Mierzwa, Jennifer Shah, Keith Casper
Association of initial abemaciclib dosing with duration of medication use in patients with stage II/III breast cancer on endocrine therapy.
Alexis Espinal, Xueting Tao, Kelley Kidwell, Norah Henry
Change in practice patterns over time for endocrine therapy (ET) and radiation therapy (RT) in women with breast cancer age 65 and older.
Aubrey Stickland, Xueting Tao, Kelley Kidwell, Norah Henry
Medical oncologist–reported challenges of treating metastatic cancer.
Nathaniel Wilson, Paul Abrahamse, Allison Kurian, Sarah Hawley, Ann Hamilton, Kevin Ward, Steven Katz, Christine Veenstra
Treatment intensification in veterans with metastatic prostate cancer.
Megan Caram, Phoebe Tsao, Kyle Kumbier, Jennifer Burns, Jordan Sparks, Archana Radhakrishnan, Jennifer Lee, Amanda Malus, Lauren Gauntlett, Samuel Washington III, Timothy Hofer, Lauren Wallner, Brent Hollenbeck, Vahakn Shahinian, Ted Skolarus
Development and implementation of a home bortezomib injection program in the US (Ann Arbor VA Close to Me).
Daria Brinzevich, Virginia Falvello, Dana Carelli, Brian Bazzell, Tal Higashimoto, Tyler Gipson, Jenna Shields, Vida Passero, Jason Chen
The value of integrating urology and oncology real-world data for understanding prostate cancer management.
Ruth PeBenito, Brandon Nathasingh, Herman Ray III, Sheenu Chandwani, Todd Morgan
Oral microbiome diversity and oral human papillomavirus-associated differences in Black vs. White individuals.
Morgan Byrd, Shelly Han, Deesha Bhaumik, Nosa Osazuwa-Peters